Cytokinetics Inc (NASDAQ:CYTK)

CAPS Rating: 1 out of 5

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer.

CYTK News and Commentary

Caps

How do you think CYTK will perform against the market?

Add Stock to CAPS Watchlist

All Players

164 Outperform
20 Underperform
 

All-Star Players

27 Outperform
8 Underperform
 

Wall Street

8 Outperform
1 Underperform
 

Top CYTK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.84)
Submitted August 23, 2013

This is kind of a risky pick, in that I'm betting that the stock will rebound ahead of the presentation of ATOMIC-AHF results at the ESC conference in early September. That doesn't give me a lot of time to escape the pick ahead of data. Thus far.… More

zzlangerhans (99.84)
Submitted July 15, 2013

After being nearly left for dead in 2012, Cytokinetics is enjoying a resurgence on the back of deals with Amgen to expand the omecantiv partnership to Japan and a new deal with Astellas for CK-2127107. The omecantiv deal is especially positive for… More

CYTK VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about CYTK.

Recs

0
Member Avatar mrbill6 (< 20) Submitted: 12/7/2017 6:07:58 AM : Outperform Start Price: $7.85 CYTK Score: +5.71

expected rise at least 50% over the next 12 months based on consensus price targets supplied by FactSet

Recs

0
Member Avatar ptanabe (24.13) Submitted: 9/9/2014 1:25:21 PM : Outperform Start Price: $3.67 CYTK Score: +95.53

ken

Recs

0
Member Avatar OKwarrior (41.12) Submitted: 6/6/2014 1:19:10 AM : Outperform Start Price: $4.88 CYTK Score: +35.37

It is down, but far from out. I am hoping for a rebound. They do have a cardiac drug remaining in the pipeline that has more than a frozen particulate sphere's chance in Hades

Leaderboard

Find the members with the highest scoring picks in CYTK.

Score Leader

PennyStockFool

PennyStockFool (29.47) Score: +249.04

The Score Leader is the player with the highest score across all their picks in CYTK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
PennyStockFool 29.47 12/4/2008 Underperform 1Y $12.06 -30.35% +218.69% +249.04 1 Comment
salesgenieshort < 20 10/6/2008 Underperform 5Y $21.90 -61.64% +155.18% +216.83 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $17.82 -52.86% +140.71% +193.57 0 Comment
snaphooks < 20 9/10/2008 Underperform 1Y $27.72 -69.70% +122.01% +191.70 1 Comment
snoopaloop 37.09 11/20/2006 Underperform 5Y $46.32 -81.87% +101.95% +183.82 0 Comment
kkubek 63.77 12/29/2006 Underperform NS $44.10 -80.95% +98.88% +179.83 0 Comment
henrythomas100 < 20 3/23/2007 Underperform NS $42.30 -80.14% +96.57% +176.71 0 Comment
bugeang 91.44 6/25/2008 Underperform 5Y $21.72 -61.33% +108.78% +170.10 0 Comment
jeffp1985 58.06 11/1/2007 Underperform 3M $31.38 -73.23% +83.22% +156.45 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 70.55 10/13/2014 Outperform 5Y $3.37 +149.26% +40.24% +109.02 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.08 7/1/2013 Underperform 3W $12.57 -33.17% +65.16% +98.34 0 Comment
TrackPiperJaff 85.03 1/4/2013 Outperform NS $4.34 +93.37% +82.58% +10.79 0 Comment
TrackCowenandCo 85.92 8/1/2012 Outperform NS $4.26 +97.21% +92.15% +5.06 0 Comment
TrackCanaccord < 20 11/19/2009 Outperform NS $21.12 -60.23% +139.54% -199.77 0 Comment
TrackWedbush 87.10 3/20/2009 Outperform NS $10.80 -22.22% +247.33% -269.55 0 Comment
TrackCreditSuiss 90.51 7/19/2007 Outperform NS $33.24 -74.73% +80.77% -155.50 0 Comment
TrackRodmanRen < 20 1/4/2007 Outperform NS $49.68 -83.09% +100.29% -183.39 0 Comment
TrackLazardCapit 78.98 1/4/2007 Outperform NS $49.68 -83.09% +100.29% -183.39 0 Comment
TrackCantorFitz 21.47 10/4/2006 Outperform NS $37.32 -77.49% +112.73% -190.22 0 Comment
TrackNeedham 91.44 9/6/2006 Outperform NS $42.00 -42.71% -19.63% -23.08 10/29/2009 @ $24.06 0 Comment

Featured Broker Partners